Edyta Paradowska

Summary

Affiliation: Polish Academy of Sciences
Country: Poland

Publications

  1. doi request reprint Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants
    Edyta Paradowska
    Laboratory of Molecular Virology and Biological Chemistry, Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland
    J Clin Virol 58:271-5. 2013
  2. doi request reprint Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections
    E Paradowska
    Institute of Medical Biology, Polish Academy of Sciences, Laboratory of Molecular Virology and Biological Chemistry, Lodowa 106, 93 232, Lodz, Poland
    Eur J Clin Microbiol Infect Dis 31:1335-45. 2012
  3. ncbi request reprint Detection of cytomegalovirus in human placental cells by polymerase chain reaction
    Edyta Paradowska
    Center for Medical Biology, Polish Academy of Sciences, Laboratory of Molecular Virology and Biological Chemistry, Lodz, Poland
    APMIS 114:764-71. 2006
  4. doi request reprint Mannan-binding lectin-2 (MBL2) gene polymorphisms in prenatal and perinatal cytomegalovirus infections
    Agnieszka Szala
    Laboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93 232 Lodz, Poland
    Mol Immunol 48:2203-6. 2011
  5. ncbi request reprint Modification of selected anti-HCMV drugs with lipophilic boron cluster modulator
    Agnieszka B Olejniczak
    Institute of Medical Biology, Polish Academy of Sciences, Laboratory of Molecular Virology and Biological Chemistry, 106 Lodowa St, 93 232 Lodz, Poland
    Acta Pol Pharm 70:489-504. 2013
  6. ncbi request reprint Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates
    Zbigniew J Lesnikowski
    Center of Medical Biology, Laboratory of Molecular Virology and Biological Chemistry, Polish Academy of Sciences, 106 Lodowa Street, Lodz 93 232, Poland
    Bioorg Med Chem 13:4168-75. 2005
  7. ncbi request reprint [Drugs against human cytomegalovirus]
    Zbigniew J Lesnikowski
    Department of Virology, Royal Free and University College Medical School, London
    Pol Merkur Lekarski 13:242-9. 2002

Collaborators

Detail Information

Publications7

  1. doi request reprint Distribution of cytomegalovirus gN variants and associated clinical sequelae in infants
    Edyta Paradowska
    Laboratory of Molecular Virology and Biological Chemistry, Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland
    J Clin Virol 58:271-5. 2013
    ..Human cytomegalovirus (HCMV) is the most widespread cause of congenital infection. The effects of various viral strains and viral loads on the infection outcome have been under debate...
  2. doi request reprint Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections
    E Paradowska
    Institute of Medical Biology, Polish Academy of Sciences, Laboratory of Molecular Virology and Biological Chemistry, Lodowa 106, 93 232, Lodz, Poland
    Eur J Clin Microbiol Infect Dis 31:1335-45. 2012
    ..0002 and p=0.040 respectively). There was no association between specific gB subtypes in all patients groups (p=0.463). There was no correlation between HCMV genotypes and the outcome...
  3. ncbi request reprint Detection of cytomegalovirus in human placental cells by polymerase chain reaction
    Edyta Paradowska
    Center for Medical Biology, Polish Academy of Sciences, Laboratory of Molecular Virology and Biological Chemistry, Lodz, Poland
    APMIS 114:764-71. 2006
    ..Our results demonstrated that detection of HCMV DNA in placental tissues by DNA amplification provides a specific and sensitive method for diagnosis of intrauterine HCMV infection...
  4. doi request reprint Mannan-binding lectin-2 (MBL2) gene polymorphisms in prenatal and perinatal cytomegalovirus infections
    Agnieszka Szala
    Laboratory of Immunobiology of Infections, Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93 232 Lodz, Poland
    Mol Immunol 48:2203-6. 2011
    ..The distribution of MBL2 haplotypes was similar between the groups studied. These data suggest MBL does not have a major influence on susceptibility to prenatal or perinatal CMV infections...
  5. ncbi request reprint Modification of selected anti-HCMV drugs with lipophilic boron cluster modulator
    Agnieszka B Olejniczak
    Institute of Medical Biology, Polish Academy of Sciences, Laboratory of Molecular Virology and Biological Chemistry, 106 Lodowa St, 93 232 Lodz, Poland
    Acta Pol Pharm 70:489-504. 2013
    ..The compounds were active against HCMV or HSV-1 by cytopathic effect or plaque reduction assays. None of the tested compounds had activity against HPIV-3 or VSV...
  6. ncbi request reprint Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates
    Zbigniew J Lesnikowski
    Center of Medical Biology, Laboratory of Molecular Virology and Biological Chemistry, Polish Academy of Sciences, 106 Lodowa Street, Lodz 93 232, Poland
    Bioorg Med Chem 13:4168-75. 2005
    ..The low toxicity of conjugate type of 6 together with its high partition coefficient suggest that judicially designed derivatives of metallacarboranes can be considered as potential boron carriers for BNCT...
  7. ncbi request reprint [Drugs against human cytomegalovirus]
    Zbigniew J Lesnikowski
    Department of Virology, Royal Free and University College Medical School, London
    Pol Merkur Lekarski 13:242-9. 2002
    ..In this outline we present anti-CMV drugs currently in clinical use and give examples of new molecules under laboratory and clinical development...